North Star Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-500
| Closed | -$16.6K | – | 1347 |
|
|
2022
Q4 | $16.6K | Hold |
500
| – | – | ﹤0.01% | 768 |
|
|
2022
Q3 | $16K | Hold |
500
| – | – | ﹤0.01% | 733 |
|
|
2022
Q2 | $15K | Hold |
500
| – | – | ﹤0.01% | 754 |
|
|
2022
Q1 | $13K | Hold |
500
| – | – | ﹤0.01% | 830 |
|
|
2021
Q4 | $10K | Hold |
500
| – | – | ﹤0.01% | 914 |
|
|
2021
Q3 | $10K | Hold |
500
| – | – | ﹤0.01% | 872 |
|
|
2021
Q2 | $11K | Hold |
500
| – | – | ﹤0.01% | 844 |
|
|
2021
Q1 | $13K | Hold |
500
| – | – | ﹤0.01% | 759 |
|
|
2020
Q4 | $9K | Hold |
500
| – | – | ﹤0.01% | 805 |
|
|
2020
Q3 | $8K | Hold |
500
| – | – | ﹤0.01% | 789 |
|
|
2020
Q2 | $12K | Hold |
500
| – | – | ﹤0.01% | 699 |
|
|
2020
Q1 | $4K | Buy |
+500
| New | +$4.21K | ﹤0.01% | 866 |
|
|
2018
Q4 | – | Sell |
-52,935
| Closed | -$789K | – | 1106 |
|
|
2018
Q3 | $789K | Buy |
52,935
+60
| +0.1% | +$930 | 0.09% | 231 |
|
|
2018
Q2 | $841K | Hold |
52,875
| – | – | 0.1% | 225 |
|
|
2018
Q1 | $751K | Buy |
52,875
+975
| +2% | +$14.4K | 0.09% | 226 |
|
|
2017
Q4 | $727K | Sell |
51,900
-1,175
| -2% | -$17.2K | 0.09% | 221 |
|
|
2017
Q3 | $759K | Hold |
53,075
| – | – | 0.1% | 217 |
|
|
2017
Q2 | $836K | Sell |
53,075
-30,000
| -36% | -$432K | 0.11% | 196 |
|
|
2017
Q1 | $1.15M | Buy |
83,075
+42,775
| +106% | +$598K | 0.16% | 158 |
|
|
2016
Q4 | $713K | Buy |
+40,300
| New | +$708K | 0.11% | 197 |
|
Other funds holding VIVO
North Star Investment Management's VIVO Position: Q1 2023 in Review
North Star Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 500 shares — an estimated $16.6K sold.
North Star Investment Management first reported a position in VIVO in Q4 2016 and held it in 20 quarters. The position peaked at $1.15M in Q1 2017. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- North Star Investment Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- North Star Investment Management sold 500 Meridian Bioscience Inc shares in Q1 2023, an estimated $16.6K.
- North Star Investment Management first reported a position in Meridian Bioscience Inc in Q4 2016 and held it in 20 quarters.
- North Star Investment Management's Meridian Bioscience Inc position peaked at $1.15M in Q1 2017.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on North Star Investment Management's 13F filing for Q1 2023, filed 27 Apr 2023.